- Home
- NXL vs FTFT Comparison
NXL vs FTFT Comparison
Compare NXL & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- FTFT
- Stock Information
- Founded
- NXL 2010
- FTFT N/A
- Country
- NXL United States
- FTFT United States
- Employees
- NXL N/A
- FTFT N/A
- Industry
- NXL Medical Specialities
- FTFT Business Services
- Sector
- NXL Health Care
- FTFT Consumer Discretionary
- Exchange
- NXL Nasdaq
- FTFT Nasdaq
- Market Cap
- NXL 10.0M
- FTFT 8.7M
- IPO Year
- NXL 2022
- FTFT N/A
- Fundamental
- Price
- NXL $3.23
- FTFT $0.30
- Analyst Decision
- NXL Hold
- FTFT
- Analyst Count
- NXL 1
- FTFT 0
- Target Price
- NXL N/A
- FTFT N/A
- AVG Volume (30 Days)
- NXL 533.6K
- FTFT 406.2K
- Earning Date
- NXL 11-08-2024
- FTFT 11-19-2024
- Dividend Yield
- NXL N/A
- FTFT N/A
- EPS Growth
- NXL N/A
- FTFT N/A
- EPS
- NXL N/A
- FTFT N/A
- Revenue
- NXL $162,078.00
- FTFT $18,543,659.00
- Revenue This Year
- NXL $56.86
- FTFT N/A
- Revenue Next Year
- NXL $167.44
- FTFT N/A
- P/E Ratio
- NXL N/A
- FTFT N/A
- Revenue Growth
- NXL 26.00
- FTFT N/A
- 52 Week Low
- NXL $0.25
- FTFT $0.26
- 52 Week High
- NXL $4.49
- FTFT $2.60
- Technical
- Relative Strength Index (RSI)
- NXL 42.43
- FTFT 40.23
- Support Level
- NXL $3.25
- FTFT $0.26
- Resistance Level
- NXL $4.49
- FTFT $0.52
- Average True Range (ATR)
- NXL 0.35
- FTFT 0.05
- MACD
- NXL -0.17
- FTFT -0.01
- Stochastic Oscillator
- NXL 7.26
- FTFT 21.50
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.